Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma

doi:10.3748/wjg.v21.i46.13101

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 46

This Article

(361)

(484)

(0)

(8972)

(17)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastroenterol. Dec 14, 2015; 21(46): 13101-13112
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13101

Table 1 Patient characteristics n (%)

Characteristics	Parameter	Patients
No. of patients		65 (100)
Sex
	Male	51 (78)
	Female	14 (22)
Age, yr
	Median	71
	Minimum-Maximum	26-93
Viral hepatitis
	HCV	35 (54)
	HBV	9 (14)
	None	21 (32)
Child-Pugh classification
	A	38 (58)
	B	24 (37)
	C	2 (3)
	NA	1 (2)
ECOG perfomance status
	0	16 (25)
	1-2	43 (66)
	3	6 (9)
Previous treatments
	Surgery	24 (37)
	RFA	28 (43)
	TACE	49 (75)
	Sorafenib	13 (20)
	Radiation	7 (11)
BCLC stage
	C	59 (91)
	D	6 (9)
AFP (ng/mL)
	Median	256
	Minimum-Maximum	1-240700
PIVKA II (mAU/mL)
	Median	1431
	Minimum-Maximum	8-316400

ECOG: Eastern Cooperative Oncology Group; BCLC: Barcelona Clinic Liver Cancer staging system; AFP: Alpha fetoprotein; PIVKA II: Proteins induced by vitamin K absence; HCV: Hepatitis C virus; HBV: Hepatitis B virus; RFA: Radiofrequency ablation; TACE: Transarterial chemoembolization; NA: Not available.

Full Size Table

Citation: Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol 2015; 21(46): 13101-13112
URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13101.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13101

Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol 2015; 21(46): 13101-13112 [PMID: 26673627 DOI: 10.3748/wjg.v21.i46.13101]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.